DocuSign CFO Disposes 9,509 Shares; Sales Executed via Rule 10b5-1
Rhea-AI Filing Summary
DocuSign Chief Financial Officer Blake Grayson sold a total of 9,509 shares of DocuSign, Inc. (ticker DOCU) on 09/17/2025 under a pre-established Rule 10b5-1 trading plan. The sales consisted of 5,658 shares at prices ranging from $82.22 to $83.18 and 3,851 shares at prices ranging from $83.20 to $83.65. Following the transactions the reporting person beneficially owned 116,011 shares after the first sale and 112,160 shares after the second sale, reported as direct ownership. The Form 4 was signed by an attorney-in-fact.
Positive
- Sales were executed under a Rule 10b5-1 plan, indicating pre-authorized trading rather than ad-hoc insider timing.
- Filing discloses price ranges for the sales and offers to provide per-price quantities on request, supporting transparency.
- Reporting person retains significant direct ownership (112,160 shares reported after the second sale).
Negative
- Form 4 does not state ownership as a percentage of outstanding shares, limiting assessment of economic stake relative to company size.
Insights
TL;DR: Insider sales by the CFO totaled 9,509 shares under a Rule 10b5-1 plan, with reported direct ownership remaining material.
The filing documents routine, pre-planned disposals rather than open-market timing. Sales were executed through a Rule 10b5-1 plan, which indicates pre-authorized trades and reduces likelihood these reflect new, contemporaneous company-specific material information. The remaining direct holdings (reported as 112,160 shares after the second transaction) show the CFO retains a meaningful stake, though the Form 4 does not state the percentage ownership relative to outstanding shares. Transactions were at prices between $82.22 and $83.65, and the filer has offered to provide a breakdown of quantities per price on request.
TL;DR: Sales are documented and executed under a documented plan; disclosure appears compliant and transparent.
The Form 4 clearly discloses the relationship (Chief Financial Officer), the Rule 10b5-1 plan usage, and price ranges for the executed sales with an offer to provide granularity on request. The signature by an attorney-in-fact is included, which is acceptable where authorized. There is no indication in the filing of other derivative transactions or amendments. From a governance perspective, the filing meets standard disclosure practices for insider disposals.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,658 | $82.95 | $469K |
| Sale | Common Stock | 3,851 | $83.33 | $321K |
Footnotes (1)
- The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. The shares were sold at prices ranging from $82.22 to $83.18. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $83.20 to $83.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
FAQ
What insider transactions were reported for DOCU on 09/17/2025?
Were the sales pre-planned or ad-hoc?
Who signed the Form 4 for the reporting person?